PEO
- Product code
- PEO
- Device name
- Fungal Organisms, Nucleic Acid-Based Assay
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.3365
- Medical specialty
- Microbiology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 1
- Summaries archived here
- 1 (direct download)
- 510(k) clearances (all years, FDA)
- 2 (all years; only the last 3 years are listed here)
FDA classification definition
A qualitative multiplexed in vitro diagnostic device to detect and identify fungal organisms in positive blood cultures.
510(k) clearances, last 3 years (1)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K240627 | 2024-06-04 | Luminex Corporation | LIAISON PLEX Yeast Blood Culture Assay |
Official FDA classification page: PEO
Classification and pathway per current FDA publications. Data from openFDA (CC0).